These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Gastric inhibitory peptide (GIP), pancreatic glucagon and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity. Gespach C, Emami S, Rosselin G. Biochem Biophys Res Commun; 1984 Apr 30; 120(2):641-9. PubMed ID: 6329177 [Abstract] [Full Text] [Related]
31. Comparison of pancreatic responses to portal and systemic secretin and VIP in cats. Konturek SJ, Domschke S, Domschke W, Wünsch E, Demling L. Am J Physiol; 1977 Feb 30; 232(2):E156-8. PubMed ID: 842623 [Abstract] [Full Text] [Related]
32. Effect of neurotensin on regional intestinal blood flow in the dog. Baća I, Mittmann U, Feurle GE, Haas M, Müller T. Res Exp Med (Berl); 1981 Feb 30; 179(1):53-8. PubMed ID: 7268217 [Abstract] [Full Text] [Related]
35. Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic secretion. Konturek SJ, Pucher A, Radecki T. J Physiol; 1976 Feb 30; 255(2):497-509. PubMed ID: 1255530 [Abstract] [Full Text] [Related]
37. Effect of synthetic chicken vasoactive intestinal peptide on pancreatic blood flow and on exocrine and endocrine secretions of the pancreas in dogs. Inoue K, Kawano T, Shima K, Kim T, Suzuki T, Tobe T, Takeyama M, Yajima H. Dig Dis Sci; 1983 Aug 30; 28(8):724-32. PubMed ID: 6347571 [Abstract] [Full Text] [Related]
38. Comparison of vasoactive intestinal peptide (VIP) and secretin in gastric secretion and mucosal blood flow. Konturek SJ, Dembiński A, Thor P, Król R. Pflugers Arch; 1976 Jan 30; 361(2):175-81. PubMed ID: 765958 [Abstract] [Full Text] [Related]
39. Different mechanisms of action of vasoactive intestinal polypeptide (VIP) and glucagon on intestinal secretion. Mailman D. Gastroenterology; 1977 Dec 30; 73(6):1463-5. PubMed ID: 913990 [No Abstract] [Full Text] [Related]